Chloroquine Phosphate Manufacturing Plant Project Report 2024

The report is the result of extensive primary and secondary research, offering a detailed analysis of current market trends. It profiles key industry players, giving insights into their market strategies, production capacities, and financial performance, which are crucial for benchmarking and competitive analysis.

It delves into historical, current, and forecasted price trends, helping stakeholders understand market dynamics and price volatility. The report provides a thorough analysis of the mass balance and raw materials requirements, ensuring a clear understanding of the input-output ratios essential for efficient production. Detailed examinations of the various unit operations integral to the chloroquine phosphate manufacturing process are included, highlighting process optimisation techniques and technological advancements.

The report presents a comprehensive capital cost analysis, detailing the financial investment required for setting up a chloroquine phosphate plant. This includes an exhaustive breakdown of costs associated with raw materials, catchem, utilities, labour, packaging, transportation, land acquisition, construction, and machinery. Additionally, it offers an in-depth look at the operating costs, providing clarity on the recurring expenses involved in running the plant.

Projected profit margins and optimal product pricing strategies are outlined, offering guidance on maximising profitability. The report also addresses regulatory frameworks, environmental impacts, and sustainability measures pertinent to the chloroquine phosphate industry.

About Chloroquine Phosphate

Chloroquine phosphate is an antimalarial drug used to prevent and treat malaria. It is also occasionally used for amebiasis, rheumatoid arthritis, and lupus erythematosus. Chloroquine phosphate is taken orally and is rapidly absorbed in the gastrointestinal tract. It is metabolized in the liver and excreted primarily unchanged in urine. Overdose can be fatal, with symptoms including sleepiness, vision changes, seizures, and heart problems.

Properties of Chloroquine Phosphate

Chloroquine phosphate is a synthetic 4-aminoquinoline compound with the chemical formula C18H26ClN3O4P. It is a white, crystalline powder that is soluble in water and alcohol. The molecular weight of chloroquine phosphate is 515.87 g/mol. It has a melting point range of 188-192°C. It has a pH of 3.5 to 4.5 in a 10% aqueous solution. The ultraviolet spectrum of chloroquine in neutral methanol solution shows absorption peaks at 250 nm and 343 nm. Chloroquine phosphate is rapidly and extensively absorbed after oral administration, with a bioavailability of 52-102% for oral solutions and 67-114% for oral tablets.

Manufacturing Process of Chloroquine Phosphate

Chloroquine phosphate is manufactured through a condensation reaction between 4,7-dichloroquinoline, sodium sulfite, and N, N-diisopropylethylamine in isopropanol. 2-amino-5-diethylaminopentane is then added, and the mixture is heated to 133-138°. Next, the reaction mixture is poured into water, and the pH is adjusted to alkaline using sodium hydroxide. Isopropyl acetate is used to extract the product, and the organic layer is washed to neutrality. The organic layer is then concentrated to precipitate the solid chloroquine product, which is filtered and dried. Finally, the dry chloroquine is dissolved in aqueous ethanol, and phosphoric acid is slowly added to form the chloroquine phosphate salt. The mixture is heated, cooled, filtered, and dried to obtain the final product.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Synthesis of Chloroquine Phosphate

Below are the primary steps involved in the making of chloroquine phosphate.

Synthesis of 4,7-Dichloroquinoline

The first step in the synthesis of chloroquine phosphate is the production of 4,7-dichloroquinoline. This is achieved through a series of reactions starting with aniline and phosphorus oxychloride.

Step 1: Nitration of Aniline

Aniline is nitrated using a mixture of concentrated sulfuric acid (H2SO4) and nitric acid (HNO3) to produce 4-nitroaniline.

C6H5NH2 + HNO3 → C6H4(NO2) NH2 + H2O

Step 2: Reduction of 4-Nitroaniline

4-Nitroaniline is then reduced to 1,4-phenylenediamine using a reducing agent such as iron and hydrochloric acid.

C6H4(NO2) NH2 + 3Fe + 6HCl → C6H4(NH2)2 + 3FeCl2 + 2H2O

Step 3: Synthesis of 4,7-Dichloroquinoline

1,4-Phenylenediamine reacts with phosphorus oxychloride (POCl3) and ethyl cyanoacetate to form 4,7-dichloroquinoline.

C6H4(NH2)2 + POCl3 + 2C4H5NO2 → C9H5Cl2N + 2C2H5OH + PCl3 + H2O

Synthesis of Chloroquine Base

The next step involves the synthesis of the chloroquine base from 4,7-dichloroquinoline.

Step 1: Reaction with Diethylamine

4,7-Dichloroquinoline reacts with diethylamine to form 4,7-dichloroquinoline-N-diethylamine.

C9H5Cl2N + (C2H5)2NH → C9H5ClN(C2H5)2 + HCl

Step 2: Reaction with 2-Aminoethanol

The resulting compound reacts with 2-aminoethanol to form the chloroquine base.

C9H5ClN(C2H5)2 + C2H7NO → C18H26ClN3 + H2O

Synthesis of Chloroquine Phosphate

Finally, the chloroquine base is converted into chloroquine phosphate by reacting it with phosphoric acid.

C18H26ClN3 + H3PO4 → C18H26ClN3·H3PO4

The outlined process ensures the production of high-quality chloroquine phosphate for medical use.

Applications and Drivers of Chloroquine Phosphate

Chloroquine phosphate has been used as an antimalarial drug for decades and remains an important tool in the fight against this disease. It is also used in the treatment of certain autoimmune disorders and liver diseases. As research continues to uncover new potential applications for this versatile compound, the market is expected to grow further. Additionally, manufacturers are investing in research and development to create more effective and user-friendly formulations, which can drive demand and increase the overall value of the market.

Key Features of the Chloroquine Phosphate Production Cost Report:

This production cost analysis report by Expert Market Research scrutinises the chloroquine phosphate manufacturing process, offering a comprehensive overview necessary for stakeholders considering venturing into this sector. Based on the latest economic data, the report encompasses detailed insights into the primary process flow, raw material requirements, reactions involved, utility costs, operating costs, capital investments, pricing strategies, and profit margins. This report is an indispensable resource for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake in the chloroquine phosphate industry. It equips them with essential information and strategic insights to effectively navigate the complexities of the market.

The following sections detail the comprehensive scope of the prefeasibility report for a chloroquine phosphate production plant:

• Market Dynamics and Trends: This section analyses the prevailing market conditions, growth drivers, and trends impacting the chloroquine phosphate industry. It offers a thorough examination of demand fluctuations and projections.

• Geographic Analysis: Detailed insights into the major regions active in chloroquine phosphate production and consumption, highlighting regional market specifics and growth potential.

• Key Industry Players: Profiles of leading manufacturers in the chloroquine phosphate sector, outlining their market share, strategic positions, and operational strengths.

• Price Fluctuations: Analysis of historical, current, and projected price trends, providing stakeholders with essential pricing intelligence.

• Technical Specifications and Process Description: A detailed overview of the chloroquine phosphate production process including the technology used and innovations within the industry.

• Raw Material Requirements and Sourcing: Evaluation of necessary raw materials, their sourcing strategies, and cost implications.

• Utility Requirements and Costs: Detailed analysis of utilities needed to produce chloroquine phosphate, such as electricity, steam, and process water along with their cost assessments. 

• Labour Force Dynamics: Insights into manpower requirements, including skill specifications and labour cost projections.

• Packaging Needs: Overview of packaging requirements for chloroquine phosphate to ensure product integrity and cost efficiency.

• Logistics and Transportation: Examination of transportation needs and logistics planning for distribution and supply chain efficiency.

• Capital and Operating Costs: An in-depth look at investment requirements, including land acquisition and its development cost, civil work costs, construction, machinery procurement, and ongoing operational expenses, such as salaries and wages, plant overheads, tax and insurance as well as packaging, transportation, and administration costs.

• Financial Performance and Profitability Analysis: Projected profit margins and return on investment based on current market and operational parameters.

• Product Pricing Strategy: Recommendations on pricing mechanisms based on industry benchmarks and production costs.

• Environmental Impact and Regulatory Compliance: Analysis of environmental considerations and compliance with local and international regulations.

• Risk Assessment and Mitigation Strategies: Identification of potential risks associated with chloroquine phosphate production and strategies to mitigate them.

Key Questions Addressed:

• What are the detailed unit operations for chloroquine phosphate production?

• Who are major technology licensors with their process evaluation?

• How are raw materials or catchem procured and what are their cost implications?

• What utilities are essential for production and what will they cost?

• What are the labour requirements and how does this affect operational costs?

• What packaging solutions are optimal for cost and efficiency?

• What logistical arrangements are necessary for efficient product distribution?

• What are the estimated land and construction costs for a new chloroquine phosphate plant?

• How can profitability be maximised in the chloroquine phosphate market?

• What pricing strategy should be adopted for chloroquine phosphate to remain competitive?

This prefeasibility report aims to equip potential investors and existing manufacturers with crucial insights to make informed decisions in the chloroquine phosphate industry.